Woodline Partners LP Viking Therapeutics, Inc. Transaction History

Woodline Partners LP

$13.5 Billion
Q4 2024

A detailed history of Woodline Partners LP transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 93,294 shares of VKTX stock, worth $2.39 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

93,294

Previous 63,819 46.19%

Holding current value

$2.39 Million

Previous $4.04 Million 7.08%

% of portfolio

0.03%

Previous 0.04%

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$38.28 - $78.03 $1.13 Million - $2.3 Million	29,475 Added 46.19%	93,294 $3.75 Million
Q3 2024 Nov 14, 2024	SELL	$49.84 - $70.47 $80,092 - $113,245	-1,607 Reduced 2.46%	63,819 $4.04 Million
Q2 2024 Aug 14, 2024	BUY	$47.39 - $80.2 $5,592 - $9,463	118 Added 0.18%	65,426 $3.47 Million
Q1 2024 May 15, 2024	BUY	$17.4 - $94.5 $1.14 Million - $6.17 Million	65,308 New	65,308 $5.36 Million

About Viking Therapeutics, Inc.

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $1.97B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

More about VKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Account

Woodline Partners LP Viking Therapeutics, Inc. Transaction History